SEVERANCE AGREEMENT AND GENERAL RELEASESeverance Agreement • August 8th, 2024 • EyePoint Pharmaceuticals, Inc. • Laboratory analytical instruments • Massachusetts
This Severance Agreement and General Release (this “Agreement”) is entered into by Nancy S. Lurker (“Employee”) and EyePoint Pharmaceuticals, Inc. (“EyePoint” or the “Company”). This Agreement is effective only if it has been executed by the parties on or after the Separation Date and the revocation period has expired without revocation as set forth in Sections 12(f) and (g) below. This Agreement shall become effective on the 8th day after Employee signs and does not revoke this Agreement (the “Effective Date”).
